Correlates of human papillomavirus vaccine series completion among young adult female initiators.

about

Morbidity and mortality of vulvar and vaginal cancers: Impact of 2-, 4-, and 9-valent HPV vaccines HPV vaccine completion and dose adherence among commercially insured females aged 9 through 26 years in the US.

P2860

Q37135012-5A82F08E-047C-4C30-AF28-F8085940541E Q40256932-806E6BBE-10BC-4DB4-B282-3325728FB240

P2860

Correlates of human papillomavirus vaccine series completion among young adult female initiators.

Item

http://www.wikidata.org/entity/Q36978384

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Correlates of human papillomav ...... young adult female initiators.

@en

type

Item

label

Correlates of human papillomav ...... young adult female initiators.

@en

prefLabel

Correlates of human papillomav ...... young adult female initiators.

@en

P1476

Correlates of human papillomav ...... young adult female initiators.

@en

P2093

Christine McGrath

http://www.w3.org/2001/XMLSchema#string

Mahbubur Rahman

http://www.w3.org/2001/XMLSchema#string

Tabassum H Laz

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

Knowledge and early adoption of the HPV vaccine among girls and young women: results of a national survey

FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP)

Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia

Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial.

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.

Use of human papillomavirus vaccines among young adult women in the United States: an analysis of the 2008 National Health Interview Survey.

Disparities in human papillomavirus vaccine completion among vaccine initiators.

Human papillomavirus vaccine uptake among 18- to 26-year-old women in the United States: National Health Interview Survey, 2010

P304

2163-2167

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/HV.29633

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Abbey B Berenson

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25424919

http://www.w3.org/2001/XMLSchema#string

P932

4896774

http://www.w3.org/2001/XMLSchema#string

Correlates of human papillomavirus vaccine series completion among young adult female initiators.

about

P2860

P2860

Correlates of human papillomavirus vaccine series completion among young adult female initiators.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932